AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Biomarkers for CKD: Glomerular Filtration and Progression of Kidney Disease

  • Duration: 65 Minutes

Price: $59.00

Member Price: $49.00

Rating: Member Average

Other Available Formats

Format Price Member Price
CD/DVD $69.00 $59.00
CD/DVD $69.00 $59.00

This is a recorded version of the AACC webinar “Biomarkers for CKD: Glomerular Filtration and Progression of Kidney Disease” which was originally held July 10, 2012. Early detection and treatment of chronic kidney disease (CKD) reduces the incidence of cardiovascular disease and can slow or even halt the progression of patients to end-stage renal disease. Glomerular Filtration Rate (GFR), calculated using creatinine results, age, race, gender and other factors, is an important measurement of kidney function, as well as a valuable tool for early detection. Dr. Dalton discusses what GFR measures and why it’s used for assessing renal function, why plasma biomarkers of GFR should be interpreted as continuous variables and not on the basis of population reference intervals, how to use biomarkers of GFR to monitor the progression of chronic kidney disease, and how to assess the impact of biological variation and analytical precision on the clinical value of plasma biomarkers of GFR.